Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Paolo Bironzo"'
Autor:
Cesare Gridelli, Marcello Tiseo, Diego Luigi Cortinovis, Maria Rita Migliorino, Vito Barbieri, Paolo Bironzo, Alessandra Bearz, Ilaria Attili, Filippo de Marinis
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 10033-10042 (2023)
Background: ALK tyrosine kinase inhibitors (TKIs) have revolutionized the treatment and largely improved the survival outcomes of patients with NSCLC harboring ALK rearrangements. Different ALK TKI compounds have demonstrated antitumor activity in th
Externí odkaz:
https://doaj.org/article/54f230401afe47b6b58e03ea5df5f95f
Autor:
Francesca Bersani, Francesca Picca, Deborah Morena, Luisella Righi, Francesca Napoli, Mariangela Russo, Daniele Oddo, Giuseppe Rospo, Carola Negrino, Barbara Castella, Marco Volante, Angela Listì, Vanessa Zambelli, Federica Benso, Fabrizio Tabbò, Paolo Bironzo, Emanuele Monteleone, Valeria Poli, Filippo Pietrantonio, Federica Di Nicolantonio, Alberto Bardelli, Carola Ponzetto, Silvia Novello, Giorgio V. Scagliotti, Riccardo Taulli
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-19 (2023)
Abstract Background MET-driven acquired resistance is emerging with unanticipated frequency in patients relapsing upon molecular therapy treatments. However, the determination of MET amplification remains challenging using both standard and next-gene
Externí odkaz:
https://doaj.org/article/b85e50ab7db14533b177127c3b4c0360
Autor:
Giulio Rossi, Luisella Righi, Francesca Barbisan, Marcello Tiseo, Paolo Spagnolo, Federica Grosso, Pasquale Pisapia, Umberto Malapelle, Marika Sculco, Irma Dianzani, Laura Abate-Daga, Maria Cristina Davolio, Giovanni Luca Ceresoli, Domenico Galetta, Giulia Pasello, Silvia Novello, Paolo Bironzo
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 4, p 394 (2024)
The pathologic diagnosis of pleural mesothelioma is generally based on international guidelines, but no compulsory points based on different drugs approvals in different European countries are required to be reported. According to the last (2021) edi
Externí odkaz:
https://doaj.org/article/cc7d3f236f6742d4b756b908f9d42440
Autor:
Andriani Charpidou, Grigorios Gerotziafas, Sanjay Popat, Antonio Araujo, Arnaud Scherpereel, Hans-Georg Kopp, Paolo Bironzo, Gilbert Massard, David Jiménez, Anna Falanga, Anastasios Kollias, Konstantinos Syrigos
Publikováno v:
Cancers, Vol 16, Iss 2, p 450 (2024)
Cancer-associated thrombosis (CAT) is a common complication in lung cancer patients. Lung cancer confers an increased risk of thrombosis compared to other solid malignancies across all stages of the disease. Newer treatment agents, including checkpoi
Externí odkaz:
https://doaj.org/article/c582da94b43145b4bb939c5d3b7d0af0
Autor:
Iris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, Preeta Ananthanarayanan, Luisa Ricci, Sabrina Digiovanni, Simona Fontana, Francesca Napoli, Alberto Sandri, Chiara Facolmatà, Roberta Libener, Valentina Comunanza, Federica Grosso, Elena Gazzano, Francesco Leo, Riccardo Taulli, Federico Bussolino, Luisella Righi, Mauro Giulio Papotti, Silvia Novello, Giorgio Vittorio Scagliotti, Chiara Riganti, Joanna Kopecka
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-19 (2022)
Abstract Background The combination of pemetrexed and cisplatin remains the reference first-line systemic therapy for malignant pleural mesothelioma (MPM). Its activity is moderate because of tumor aggressiveness, immune-suppressive environment and r
Externí odkaz:
https://doaj.org/article/da52a5cccfcf413bae005aae8e780d71
Autor:
Mario Levis, Alessio Gastino, Greta De Giorgi, Cristina Mantovani, Paolo Bironzo, Luca Mangherini, Alessia Andrea Ricci, Umberto Ricardi, Paola Cassoni, Luca Bertero
Publikováno v:
Cancers, Vol 15, Iss 18, p 4622 (2023)
Brain metastases (BMs) represent the most frequent metastatic event in the course of lung cancer patients, occurring in approximately 50% of patients with non-small-cell lung cancer (NSCLC) and in up to 70% in patients with small-cell lung cancer (SC
Externí odkaz:
https://doaj.org/article/2139e8bc4703407b87ac5a437461972b
Autor:
Marco Tagliamento, MD, Jordi Remon, MD, PhD, Matteo Giaj Levra, MD, Andrea De Maria, MD, Paolo Bironzo, MD, PhD, Benjamin Besse, MD, PhD, Silvia Novello, MD, PhD, Laura Mezquita, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100446- (2023)
Introduction: Patients with cancer and hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are underrepresented in several clinical trials testing immune checkpoint inhibitors (ICIs). Consequently, safety and efficacy of ICI therapy in this
Externí odkaz:
https://doaj.org/article/8bb0b046a4dc4b03923440db7ca7bf49
Autor:
Maristella Bungaro, Valentina Bertaglia, Marco Audisio, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, Irene Persano, Francesca Jacobs, Chiara Baratelli, Lorena Consito, Maria Lucia Reale, Fabrizio Tabbò, Paolo Bironzo, Giorgio Vittorio Scagliotti, Silvia Novello
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 2, Iss 5, Pp 481-489 (2021)
Aim: Since SARS-CoV-2 infection rapidly spread around the world, Italy has quickly become one of the most affected countries. Healthcare systems introduced strict infection control measures to ensure optimal care, especially in frail groups such as
Externí odkaz:
https://doaj.org/article/f69b165d190241d5a0b726d234a48f47
Autor:
Andrea Mogavero, Paolo Bironzo, Luisella Righi, Alessandra Merlini, Federica Benso, Silvia Novello, Francesco Passiglia
Publikováno v:
Life, Vol 13, Iss 6, p 1291 (2023)
Lung cancer is one of the most frequently diagnosed cancers worldwide and the leading cause of cancer-related death. The 2021 World Health Organization (WHO) classification provided a detailed and updated categorization of lung adenocarcinomas with a
Externí odkaz:
https://doaj.org/article/5e032ff010a34d279b3143bd255489e5
Autor:
Paolo Bironzo, Francesco Pepe, Gianluca Russo, Pasquale Pisapia, Gianluca Gragnano, Gabriella Aquino, Silvia Bessi, Simonetta Buglioni, Federico Bartoccini, Giuseppina Ferrero, Michela Anna Bresciani, Paola Francia di Celle, Francesca Sibona, Andrea Giusti, Alessandra Movilia, Renata Mariella Farioli, Alessandra Santoro, Domenico Salemi, Stefania Scarpino, Dino Galafate, Stefania Tommasi, Rosanna Lacalamita, Davide Seminati, Elham Sajjadi, Silvia Novello, Fabio Pagni, Giancarlo Troncone, Umberto Malapelle
Publikováno v:
Diagnostics, Vol 13, Iss 4, p 629 (2023)
Lung cancer remains the leading cause of cancer deaths worldwide. International societies have promoted the molecular analysis of MET proto-oncogene, receptor tyrosine kinase (MET) exon 14 skipping for the clinical stratification of non-small cell lu
Externí odkaz:
https://doaj.org/article/9e1d4d362dda4bec9c5113fcc9e10130